We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Based on 14 analysts
Target prices reflect the market consensus (mean/high/low), not individual research firms. 40 actions collected · 29 in the last 12 months.
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 08. | Mizuho | — | Maintain | Outperform → Outperform | — | Mizuho: Outperform |
| 2026. 05. 08. | Piper Sandler | — | Upgrade | Neutral → Overweight | — | Piper Sandler: Neutral → Overweight |
| 2026. 05. 05. | UBS | — | Maintain | Neutral → Neutral | — | UBS: Neutral |
| 2026. 03. 06. | Barclays | — | Maintain | Equal-Weight → Equal-Weight | — | Barclays: Equal-Weight |
| 2026. 03. 02. | Piper Sandler | — | Maintain | Neutral → Neutral | — | Piper Sandler: Neutral |
| 2026. 02. 28. | UBS | — | Maintain | Neutral → Neutral | — | UBS: Neutral |
| 2026. 02. 28. | Mizuho | — | Maintain | Outperform → Outperform | — | Mizuho: Outperform |
| 2026. 02. 28. | Oppenheimer | — | Maintain | Outperform → Outperform | — | Oppenheimer: Outperform |
| 2026. 02. 25. | Rosenblatt | — | Maintain | Buy → Buy | — | Rosenblatt: Buy |
| 2026. 02. 24. | UBS | — | Maintain | Neutral → Neutral | — | UBS: Neutral |
| 2026. 01. 22. | BMO Capital | — | Initiate coverage | — → Outperform | — | BMO Capital: Outperform |
| 2026. 01. 21. | Oppenheimer | — | Maintain | Outperform → Outperform | — | Oppenheimer: Outperform |
| 2026. 01. 13. | Piper Sandler | — | Downgrade | Overweight → Neutral | — | Piper Sandler: Overweight → Neutral |
| 2026. 01. 13. | Barclays | — | Maintain | Equal-Weight → Equal-Weight | — | Barclays: Equal-Weight |
| 2026. 01. 06. | RBC Capital | — | Maintain | Outperform → Outperform | — | RBC Capital: Outperform |
| 2025. 11. 07. | JP Morgan | — | Maintain | Neutral → Neutral | — | JP Morgan: Neutral |
| 2025. 11. 07. | Baird | — | Maintain | Outperform → Outperform | — | Baird: Outperform |
| 2025. 11. 06. | Rosenblatt | — | Maintain | Buy → Buy | — | Rosenblatt: Buy |
| 2025. 11. 06. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2025. 10. 17. | Rosenblatt | — | Upgrade | Neutral → Buy | — | Rosenblatt: Neutral → Buy |
| 2025. 10. 08. | Barclays | — | Initiate coverage | — → Equal-Weight | — | Barclays: Equal-Weight |
| 2025. 08. 08. | Goldman Sachs | — | Maintain | Sell → Sell | — | Goldman Sachs: Sell |
| 2025. 08. 08. | UBS | — | Maintain | Neutral → Neutral | — | UBS: Neutral |
| 2025. 08. 07. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2025. 08. 07. | Oppenheimer | — | Maintain | Outperform → Outperform | — | Oppenheimer: Outperform |
| 2025. 08. 07. | Rosenblatt | — | Downgrade | Buy → Neutral | — | Rosenblatt: Buy → Neutral |
| 2025. 07. 30. | Baird | — | Maintain | Outperform → Outperform | — | Baird: Outperform |
| 2025. 07. 17. | Oppenheimer | — | Maintain | Outperform → Outperform | — | Oppenheimer: Outperform |
| 2025. 07. 08. | Keybanc | — | Maintain | Overweight → Overweight | — | Keybanc: Overweight |
| 2025. 05. 09. | UBS | — | Maintain | Neutral → Neutral | — | UBS: Neutral |
| 2025. 05. 09. | RBC Capital | — | Maintain | Outperform → Outperform | — | RBC Capital: Outperform |
| 2025. 05. 09. | Keybanc | — | Maintain | Overweight → Overweight | — | Keybanc: Overweight |
| 2025. 05. 08. | Oppenheimer | — | Maintain | Outperform → Outperform | — | Oppenheimer: Outperform |
| 2025. 05. 08. | Rosenblatt | — | Maintain | Buy → Buy | — | Rosenblatt: Buy |
| 2025. 05. 05. | Rosenblatt | — | Maintain | Buy → Buy | — | Rosenblatt: Buy |
| 2025. 04. 16. | Keybanc | — | Maintain | Overweight → Overweight | — | Keybanc: Overweight |
| 2025. 04. 15. | Mizuho | — | Maintain | Outperform → Outperform | — | Mizuho: Outperform |
| 2025. 04. 09. | JP Morgan | — | Maintain | Neutral → Neutral | — | JP Morgan: Neutral |
| 2025. 04. 01. | UBS | — | Initiate coverage | — → Neutral | — | UBS: Neutral |
| 2025. 02. 28. | Goldman Sachs | — | Downgrade | Neutral → Sell | — | Goldman Sachs: Neutral → Sell |